BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 30197329)

  • 1. The anti-cancer efficacies of diffractaic, lobaric, and usnic acid:
    Emsen B; Aslan A; Turkez H; Joughi A; Kaya A
    J Cancer Res Ther; 2018; 14(5):941-951. PubMed ID: 30197329
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro antitumor activities of the lichen compounds olivetoric, physodic and psoromic acid in rat neuron and glioblastoma cells.
    Emsen B; Aslan A; Togar B; Turkez H
    Pharm Biol; 2016 Sep; 54(9):1748-62. PubMed ID: 26704132
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytotoxic activity and antioxidant capacity of purified lichen metabolites: an in vitro study.
    Brisdelli F; Perilli M; Sellitri D; Piovano M; Garbarino JA; Nicoletti M; Bozzi A; Amicosante G; Celenza G
    Phytother Res; 2013 Mar; 27(3):431-7. PubMed ID: 22628260
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-Cancer Activity of Lobaric Acid and Lobarstin Extracted from the Antarctic Lichen Stereocaulon alpnum.
    Hong JM; Suh SS; Kim TK; Kim JE; Han SJ; Youn UJ; Yim JH; Kim IC
    Molecules; 2018 Mar; 23(3):. PubMed ID: 29538328
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lichen Acids May Be Used as A Potential Drug For Cancer Therapy; by Inhibiting Mitochondrial Thioredoxin Reductase Purified From Rat Lung.
    Ozgencli I; Budak H; Ciftci M; Anar M
    Anticancer Agents Med Chem; 2018; 18(11):1599-1605. PubMed ID: 29793415
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antimycobacterial activity of lichen metabolites in vitro.
    Ingólfsdóttir K; Chung GA; Skúlason VG; Gissurarson SR; Vilhelmsdóttir M
    Eur J Pharm Sci; 1998 Apr; 6(2):141-4. PubMed ID: 9795033
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lichen-derived compounds show potential for central nervous system therapeutics.
    Reddy RG; Veeraval L; Maitra S; Chollet-Krugler M; Tomasi S; Dévéhat FL; Boustie J; Chakravarty S
    Phytomedicine; 2016 Nov; 23(12):1527-1534. PubMed ID: 27765373
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lichen metabolites. 2. Antiproliferative and cytotoxic activity of gyrophoric, usnic, and diffractaic acid on human keratinocyte growth.
    Kumar KC; Müller K
    J Nat Prod; 1999 Jun; 62(6):821-3. PubMed ID: 10395495
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-proliferative effects of lichen-derived inhibitors of 5-lipoxygenase on malignant cell-lines and mitogen-stimulated lymphocytes.
    Ogmundsdóttir HM; Zoëga GM; Gissurarson SR; Ingólfsdóttir K
    J Pharm Pharmacol; 1998 Jan; 50(1):107-15. PubMed ID: 9504441
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of growth of U87MG human glioblastoma cells by Usnea longissima Ach.
    Emsen B; Ozdemir O; Engin T; Togar B; Cavusoglu S; Turkez H
    An Acad Bras Cienc; 2019; 91(3):e20180994. PubMed ID: 31596391
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-proliferative lichen compounds with inhibitory activity on 12(S)-HETE production in human platelets.
    Bucar F; Schneider I; Ogmundsdóttir H; Ingólfsdóttir K
    Phytomedicine; 2004 Nov; 11(7-8):602-6. PubMed ID: 15636173
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lichen secondary metabolites affect growth of Physcomitrella patens by allelopathy.
    Goga M; Antreich SJ; Bačkor M; Weckwerth W; Lang I
    Protoplasma; 2017 May; 254(3):1307-1315. PubMed ID: 27645140
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The inhibition of gastric mucosal lesion, oxidative stress and neutrophil-infiltration in rats by the lichen constituent diffractaic acid.
    Bayir Y; Odabasoglu F; Cakir A; Aslan A; Suleyman H; Halici M; Kazaz C
    Phytomedicine; 2006 Sep; 13(8):584-90. PubMed ID: 16920514
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Production and bioactivity of common lichen metabolites as exemplified by Heterodea muelleri (Hampe) Nyl.
    Hager A; Brunauer G; Türk R; Stocker-Wörgötter E
    J Chem Ecol; 2008 Feb; 34(2):113-20. PubMed ID: 18080715
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protective effects of lichen metabolites evernic and usnic acids against redox impairment-mediated cytotoxicity in central nervous system-like cells.
    Fernández-Moriano C; Divakar PK; Crespo A; Gómez-Serranillos MP
    Food Chem Toxicol; 2017 Jul; 105():262-277. PubMed ID: 28450128
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simultaneous determination of usnic, diffractaic, evernic and barbatic acids in rat plasma by ultra-high-performance liquid chromatography-quadrupole exactive Orbitrap mass spectrometry and its application to pharmacokinetic studies.
    Wang H; Yang T; Cheng X; Kwong S; Liu C; An R; Li G; Wang X; Wang C
    Biomed Chromatogr; 2018 Mar; 32(3):. PubMed ID: 29055065
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro risk assessment of usnic acid.
    Polat Z; Aydın E; Türkez H; Aslan A
    Toxicol Ind Health; 2016 Mar; 32(3):468-75. PubMed ID: 24193043
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of two lichen acids isolated from Pseudevernia furfuracea (L.) Zopf in cultured human lymphocytes.
    Emsen B; Togar B; Turkez H; Aslan A
    Z Naturforsch C J Biosci; 2018 Jul; 73(7-8):303-312. PubMed ID: 29573381
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Usnic acid and diffractaic acid as analgesic and antipyretic components of Usnea diffracta.
    Okuyama E; Umeyama K; Yamazaki M; Kinoshita Y; Yamamoto Y
    Planta Med; 1995 Apr; 61(2):113-5. PubMed ID: 7753915
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clastogenic effect of atranorin, evernic acid, and usnic acid on human lymphocytes.
    Stojanović GS; Stanković M; Stojanović IZ; Palić I; Milovanović V; Rancić S
    Nat Prod Commun; 2014 Apr; 9(4):503-4. PubMed ID: 24868868
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.